← FDA DRUG APPROVALS

FDA ANDA · ANDA089441

EXTENDED PHENYTOIN SODIUM

Sponsor: ANI PHARMS

APPLICATION
ANDA089441
TYPE
ANDA
ORIGINAL APPROVAL
1986-12-18
LATEST ACTION
1999-10-19
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

EXTENDED PHENYTOIN SODIUMDiscontinued
PHENYTOIN SODIUM 100MG EXTENDED · CAPSULE · ORAL

Approval history

1999-10-19Labeling · Supplement 5AP
1999-02-03Labeling · Supplement 3AP
1994-05-11Manufacturing (CMC) · Supplement 2AP
1987-09-28Manufacturing (CMC) · Supplement 1AP
1986-12-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →